Sol-Gel Technologies (SLGL) Operating Expenses (2017 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Operating Expenses of $4.0 million for Q1 2026, down 60.76% year-over-year from $10.1 million in Q1 2025, and down 4.76% quarter-over-quarter from $4.2 million in Q4 2025.
Sol-Gel Technologies (SLGL) Operating Expenses (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Operating Expenses for 10 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 60.76% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $20.8 million (down 21.27% YoY), while the FY2025 annual figure was $27.0 million, up 14.56% from the prior year.
- Operating Expenses eased to $4.0 million in Q1 2026 per SLGL's latest filing, from $4.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $11.4 million in Q1 2023 and bottomed at $3.8 million in Q2 2024.
- Historically, Operating Expenses has averaged $6.2 million across 5 years, with a median of $6.2 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Expenses surged 90.88% — and 2026, when it tumbled 60.76%.
- Sol-Gel Technologies' Operating Expenses stood at $6.3 million in 2022, then decreased by 6.5% to $5.9 million in 2023, then increased by 8.18% to $6.4 million in 2024, then tumbled by 34.75% to $4.2 million in 2025, then declined by 4.76% to $4.0 million in 2026.
- Business Quant data shows SLGL's Operating Expenses at $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Mn |
| Dec 31, 2025 | 4.16 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Mar 31, 2025 | 10.10 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 7.18 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 7.12 Mn |
| Mar 31, 2023 | 11.36 Mn |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 6.82 Mn |
| Sep 30, 2021 | 8.12 Mn |
| Jun 30, 2021 | 8.97 Mn |